STAT-Dx is focused on the development of near-patient testing products for healthcare professionals.
STAT-Diagnostica focuses in the development of near-patient testing products for healthcare professionals, mainly for short turnaround time applications and critical care.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 10, 2016 | Series C | €25M | 8 |
|
— | Detail |
| May 6, 2013 | Series B | €22.10M | 5 |
Kurma Partners
|
— | Detail |
| Jun 16, 2011 | Series A | €2M | 1 |
Ysios Capital
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series C |
AXIS Telekom
|
— | Series C |
Boehringer Ingelheim Venture Fund
|
— | Series C |
Caixa Capital Risc
|
— | Series C |
|
|
— | Series C |
Kurma Partners
|
— | Series C |
Next47
|
— | Series C |
Ysios Capital
|
— | Series C |